Patent · US Active

Use of fused heteroaromatic pyrrolidones for treatment and prevention of diseases in animals

US11077111B2 · kind B2 · utility

0Cited by

2References

15Claims

0Family size

Assignee

Bayer Animal Health GmbH · DE

Inventors

Nils Griebenow · Milford, US
Maria De Lourdes MOTTIER · Langenfeld, DE
Gerald Beddies · Leverkusen, DE
Jörg Cramer · Wermelskirchen, DE
Ulf Bömer · Glienicke, DE
Iring HEISLER · Düsseldorf, DE

Key dates

Filing date	Oct 15, 2018
Grant date	Aug 3, 2021
Priority date	—
Expiry date	Oct 15, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to the use of fused heteroaromatic pyrrolidones for treatment and/or prophylaxis of allergic and/or inflammatory diseases in animals and to the use thereof for production of medicaments for treatment and/or prophylaxis of allergic and/or inflammatory diseases in animals, especially of atopic dermatitis and/or Flea Allergy Dermatitis, and especially in domestic animals, particularly in dogs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.